ArticleScientific reports2025

Renal impairment as a risk factor for chemotherapy induced neutropenia in the treatment of trifluridine/thymidine phosphorylase inhibitor plus bevacizumab.

Masatsune Shibutani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.